secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2025-07-28T23:59:59+00:00
Accession:  0001437749-25-023676
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health Q2 2025: TRCV grows 2% sequentially; net margin 0% on exec comp; adj EBITDA margin 30%
--------------------------------------------------------------------------------

- TRCV grew 2% sequentially, third consecutive quarter of growth and highest since Q1 2021.
- Net margin 0% due to non-recurring executive compensation; adjusted EBITDA margin 30%.
- Declared $0.12 quarterly dividend; payable Oct 10, 2025 to holders of record Sept 26, 2025.
- Repurchased 381,736 shares at $14.96 avg in Q2; $16.1M returned to shareholders YTD.
- New CEO Trent Green reinstated quarterly earnings call; cites strong customer feedback.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774925023676/0001437749-25-023676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774925023676/nrc20250725_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-023676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer